TUSCALOOSA, Ala., Sept. 23, 2025 (GLOBE NEWSWIRE) — PridCor Therapeutics today announced that Dr. David Putrino, principal investigator of the company’s SHIELD Study, participated.
Read More
September 04, 2025 10:32 ETÂ | Source:Â GlobalNewsWire-New Preprint:Â PridCor Therapeutics LLC has released a pre-print detailing a case series of 15 patients with Long COVID (LC).
Read More